Updated just now · Live
Stock analysis, price data, and AI-powered insights for AtaiBeckley Inc (ATAI).
AtaiBeckley Inc operates in the Pharmaceuticals sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ATAI.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ATAI Stock Intelligence Report. [stoxpulse.com/stocks/atai]
Disclaimer: The information on this page about AtaiBeckley Inc (ATAI) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for AtaiBeckley Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
After Fifteen Years, Tim Cook Steps Down, Wall Str...
11h ago
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in...
12h ago
StoxPulse AI results for ATAI: Pulse Score 51.5/100. Primary sentiment trends from 15 news sources and 17 SEC filings indicate a bullish outlook.
Market Cap
$1.79B
P/E Ratio
—
EPS
—
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
What's going on in today's session
AtaiBeckley Stock Skyrockets As Psychedelic Rally Extends On Trump Fast‑Track Order
These stocks are gapping in today's session
Shares of psychedelic-related biotech companies are trading higher amid continued strength after President Trump signed an executive order on accelerating medical treatments for serious mental illness.
Top movers in Monday's pre-market session
AtaiBeckley shares are trading higher after Canaccord Genuity maintained a Buy rating on the stock and raised its price target from $14 to $15.